Paul D Rubin sold $702K of BioAge Labs (BIOA)

Executed Dec 4 2025, disclosed Dec 5 2025, 1 day later.

Value, as filed

$702K

68,897 sh × $10.19

Executed

Dec 4 2025

the trade date, as filed

Disclosed

Dec 5 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

PR Paul D Rubin Chief Medical Officer profile →

Paul D Rubin (Chief Medical Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in BioAge Labs, Inc. (BIOA). The largest single filing was $702K of BIOA (68,897 sh × $10.19, as filed), executed Dec 4 2025.

The name

BIOA BioAge Labs, Inc. BIOA · Healthcare · 13 filings in 24 months ticker →

Healthcare · BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Paul D Rubin in BIOA

BIOASALE BioAge Labs, Inc. $157K
8,820 sh × $17.81
Exec Apr 1
Filed Apr 3 · 5:30 PM ET BIOASALE BioAge Labs, Inc. $151K
7,433 sh × $20.30
Exec Mar 2
Filed Mar 3 · 5:30 PM ET BIOASALE BioAge Labs, Inc. $139K
7,433 sh × $18.75
Exec Feb 2
Filed Feb 3 · 5:30 PM ET BIOASALE BioAge Labs, Inc. $216K
18,000 sh × $12.00
Exec Dec 9 2025
Filed Dec 11 2025 · 5:30 PM ET